other material
confidence high
sentiment neutral
materiality 0.60
HCW Biologics Inc. (HCWB): Nasdaq/NYSE listing notice — Nasdaq panel grants HCW Biologics extension to July 29, 2026 to regain $1 bid price compliance
HCW Biologics Inc.
- Must demonstrate bid price at or above $1 for 20 consecutive trading days by July 29, 2026.
- If deficient before September 22, 2026, Company will be immediately delisted.
- Non-compliance with any other listing rule before Sep 22 gives 7 days to advise panel.
- Regaining compliance will result in a Discretionary Panel Monitor for one year.
- Company's hearing was on May 5, 2026; panel granted extension on May 29, 2026.